WISE Srl, a Milan, Italy-based medical device company developing implantable neuromodulation leads, closed a €3m series A financing round.
The round was led by Principia, with participation from existing investors High-Tech Gründerfonds, Atlante Seed and b-to-v Partners and new investors Atlante Ventures, F3F and Antares.
The company will use the proceeds to advance the clinical development of the implants as well as to setup an ISO certified SCBI production system at a new site in Milano.
Founded in 2011 by CEO Dr. Luca Ravagnan, WISE develops novel, stretchable implantable neuromodulation leads for the treatment of a range of neurological conditions based on its proprietary Supersonic Cluster Beam Implantation (SCBI) technology.
The company aims to start marketing its product, a foldable implant for spinal cord stimulation (SCS) by 2018.
It has an office in Berlin, Germany.
FinSMEs
15/06/2015
Related News
08/11/2013: Wise Raises €1M in Equity Financing